MedTrace Logo

Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)

NCT02232750 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1320

Last updated 2021-11-03

No results posted yet for this study

Summary

The investigators hypothesize that CPD parameters will provide improved prediction of sepsis compared to currently employed laboratory parameters. These studies hold the potential to shape practitioner guidelines and improve the timeliness and accuracy with which patients with sepsis are treated today.

Conditions

  • Sepsis, Severe Sepsis and Septic Shock

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-14
Primary Completion
2015-08-15
Completion
2015-08-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02232750 on ClinicalTrials.gov